RAP 0.00% 20.5¢ raptor resources limited

Ann: Medgate enters licence agreement with ResApp Health, page-53

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 42 Posts.
    lightbulb Created with Sketch. 94
    Curios as to why there is some negativity surrounding the monthly subscription model? Particularly if there is a usage based trigger at certain points. There is so much flexibility in this model, not to mention scalability.

    e.g. 1 year deal @ $X for Y amount of usages per month - IF Y amount of usages is exceeded within the month, then a premium is paid for the excess usages OR the client is lifted up to a higher tier in the pricing model.

    Simple to administer and account for on both sides of the fence and would give the Resapp team some assurity when planning and managing server loads and other computational resources.

    Have seen this tiered pricing model work well in other health related industries where its hard to forecast volume, case by case complexity and resource consumption.

    So to me subscription model doesn't necessarily translate to less revenue in the short or long term. That said I am sure that medgate and alodokter would be getting pretty sweet deals in the short term, but it doesn't take away from the validity of the model.

    Keen to hear opposing thoughts though.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.